Drugmaker AbbVie expects Humira volume erosion to worsen
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of…
N2:BIOPH
Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product…
Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in…
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer,…
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen's…